La Crosse Virus Nucleocapsid (LACV N) (AA 90-140) Antikörper

Produktnummer ABIN5690036

Der Kaninchen Polyklonal anti-La Crosse Virus Nucleocapsid Antikörper (ABIN5690036) detektiert spezifisch La Crosse Virus Nucleocapsid in ELISA. Dieser Antikörper reagiert spezifisch mit Proben aus Virus.

Kurzübersicht für La Crosse Virus Nucleocapsid (LACV N) (AA 90-140) Antikörper (ABIN5690036)

Target: La Crosse Virus Nucleocapsid (LACV N)

Reaktivität: Virus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Unkonjugiert

Applikation: ELISA

Produktdetails

Bindungsspezifität: AA 90-140

Aufreinigung: La Crosse Virus Nucleocapsid Antibody is affinity chromatography purified via peptide column.

Immunogen: La Crosse virus nucleocapsid antibody was raised against an 18 amino acid peptide near the center of the La Crosse virus nucleocapsid.

The immunogen is located within amino acids 90 - 140 of La Crosse Virus Nucleocapsid.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: La Crosse virus nucleocapsid antibody can detect 10 ng La Crosse virus nucleocapsid peptide in ELISA at 1 μ,g/mL.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: La Crosse virus nucleocapsid Antibody is supplied in PBS containing 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Rift Valley Fever Virus Nucleocapsid antibody can be stored at 4°C for three months and -20°C, stable for up to one year.

Antigendetails

Target: La Crosse Virus Nucleocapsid (LACV N)

Andere Bezeichnung: La Crosse Virus Nucleocapsid

Substanzklasse: Viral Protein

Hintergrund: La Crosse Virus Nucleocapsid Antibody: La Crosse virus (LCV) is a single-stranded RNA virus that can cause encephalitis in humans and is transmitted predominantly by mosquitoes. It is often mistaken for herpes simplex encephalitis (1). During human infections, LCV initially presents as a nonspecific summertime illness with fever, headache, nausea, vomiting and lethargy. Death occurs in less than 1 % of clinical cases.

Molekulargewicht: Predicted: 26 kDa

Gen-ID: 956556

UniProt: Q8JPR0